Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Mediest is a medical AI and data science company located on the campus of Kobe University in Japan. Founded in 2021, its business covers outsourced medical data analysis, AI consulting, medical image AI annotation, and the development of medical AI and health software. Rather than being a single SaaS tool, it is closer to a custom AI services provider for medical research, PoCs, and business validation.
Based on its official website, Mediest’s core strength lies in combining a physician’s perspective with AI engineering capabilities. Its services support statistical analysis, machine learning and deep learning model design and validation, as well as modeling and interpretation of research data, clinical data, ECG data, medical images, real-world data, and more. Typical scenarios include medical research data analysis, AI theme scoping, data preparation planning, PoC design, teacher-data annotation for medical imaging, embedding AI features, and developing web applications for research or business validation. The website also showcases demo versions of its AI transcription software Sibilus and AI scheduling software ShiftAid.
The official website does not disclose pricing, plans, delivery timelines, or payment methods, so it is likely to operate mainly on a project-based quotation model. For free trials, it only clearly mentions demo versions for two products, without stating whether its outsourced services can be tried. In terms of APIs and integration, the website mentions web application development, AI feature embedding, PoCs, and business tool development, but does not provide public API documentation, SDKs, or a list of third-party system integrations. On privacy, the company publishes a personal information protection policy covering personal information management, provision to third parties, security management measures, and handling of pseudonymized processed information, but it does not disclose details on certifications, encryption, or data residency.
Its advantages are strong medical specialization: the team includes cardiovascular medicine specialists, radiology specialists, and deep learning researchers, making it suitable for projects that require medical-context understanding, annotation quality control, and interpretation of research results. It can also extend from data analysis to software implementation. The limitations are that the website lacks concrete model performance metrics, case outcomes, pricing, and SLA information, while the level of standardization is unclear. Before procurement, buyers should communicate requirements, compliance boundaries, and deliverables in detail.
Access from mainland China, payment options, and Chinese-language support are not stated in the main content, so they should be treated as “unknown.” If a China-based team needs similar services, it may be better to first evaluate local medical AI companies, medical data annotation platforms, hospital research collaboration teams, or cloud-vendor medical AI solutions, in order to reduce risks around cross-border data transfer, language communication, and compliance.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on mediest.jp official site.
mediest.jp is an Japan AI Apps provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach mediest.jp directly.